Summary

The size of the worldwide market for structural heart devices was confirmed using both top-down and bottom-up methodologies, and the sizes of various dependent submarkets were estimated. To identify and gather data for the study of this market, a variety of secondary sources have been used, including databases, industry journals, annual reports of the companies, and associations such as the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Heart Association (AHA), Structural Heart Disease Australia (SHDA), Cardiovascular Research Foundation (CRF), Heart Research Institute (HRI), Diagnostic and Interventional Cardiology (DAIC), European Society of Cardiology (ESC), and American College of Cardiology (ACC). Experts from the supply and demand sides have been interviewed as primary sources in order to gather and verify information and evaluate the structural dynamics of the heart device sector.

Research Methodology:
After secondary research provided a fundamental understanding of the worldwide Structural Heart Devices Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering Structural Heart Devices Market details, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered. The primary participants share is given below:


Structural Heart Devices Market based on Type:
• SAVR (Surgical Aortic Valve Replacement)
• TAVR (Transcatheter Aortic Valve Replacement)
• Mitral Repair (Annuloplasty)
• LAAC (Left Atrial Appendage Closure)
Structural Heart Devices Market based on Geography:
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe (RoE)
• Asia Pacific (APAC)
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
o Brazil
o Argentina
o Rest of South America
• Middle East and Africa (MEA)
o UAE
o Turkey
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
Because of its established reimbursement codes and demonstrated effectiveness in treatment procedures, the SAVR segment held a dominant revenue share of 51.8% in 2022. Surgeons favor SAVR because it offers well-defined surgical guidelines that they can refer to throughout surgeries. The market is divided into four segments based on the kind of device: mitral repair, transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR), and left atrial appendage closure (LAAC).

On the other hand, because TAVR is a minimally invasive treatment that can be used to replace a constricted aortic valve without the need for open-heart surgery, it is predicted to grow at the fastest CAGR of 10.2% over the forecast period. The need for TAVR treatments is anticipated to develop in tandem with the prevalence of aortic stenosis (AS). Furthermore, TAVR involves less physical surgery than open heart surgery. For patients who are more likely to experience complications from open-heart operations, this makes it a more appealing alternative.

Compared to prior models, the more recent TAVR devices are easier to implant, smaller, and more flexible. As a result, TAVR is now a more practical choice for more people. According to a May 2023 study that appeared in the Journal of the American College of Cardiology, after a three-year follow-up period, minimally invasive TAVR operations consistently outperformed open heart surgery in terms of clinical outcomes. The purpose of the study was to evaluate the long-term results of TAVR for patients with aortic stenosis who were enrolled in the Evolut Low Risk trial.

Due to rising healthcare spending, increased R&D, and an increase in heart disease prevalence brought on by the region's steady aging population, North America dominated the global structural heart device market and held the largest revenue share of 40.8% in 2022. Another major factor contributing to the regional supremacy is a significant demand for minimally invasive procedures.

Coronary artery bypass graft surgery (CABG) and coronary artery bypass/bypass surgery are the most common types of heart surgery, according to data released by Cedars-Sinai in January 2022. In the United States, almost 300,000 people get successful bypass surgery annually. This illustrates how common cardiovascular diseases are becoming across the country.

However, throughout the course of the projection period, the Asia Pacific area is expected to grow at the fastest rate, with a CAGR of 10.0%. This can be linked to rising healthcare costs, a greater understanding of heart conditions, improved newborn screening initiatives, and enhanced access to healthcare in the area. Additionally, the demand for structural heart devices in the region is anticipated to rise in the future because of the increased life expectancy and affordable cost of these goods.

The manufacturers of these devices are investigating this area's unexplored development potential. For example, Abbott announced the launch of Navitor in India in December 2022. It is a minimally invasive transcatheter aortic valve implantation (TAVI) technique recommended for patients at high or extreme surgical risk who have severe aortic stenosis. By stopping blood from seeping around the valve, the ground-breaking gadget advances transcatheter aortic valve replacement procedures.

• This report illustrates the most vital attributes of the Structural Heart Devices Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Structural Heart Devices Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Structural Heart Devices Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Structural Heart Devices Market.

ページTOPに戻る

Table of Contents

Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Type: Market Size & Analysis
5.1. Overview
5.2. SAVR (Surgical Aortic Valve Replacement)
5.3. TAVR (Transcatheter Aortic Valve Replacement)
5.4. Mitral Repair (Annuloplasty)
5.5. LAAC (Left Atrial Appendage Closure)
6. Geography: Market Size & Analysis
6.1. Overview
6.2. North America (U.S., Mexico, Canada)
6.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
6.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
6.5. Latin America (Brazil, Argentina)
6.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
7. Competitive Landscape
7.1. Competitor Comparison Analysis
7.2. Market Developments
7.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
7.2.2. Product Launches and execution
8. Vendor Profiles
8.1. BOSTON SCIENTIFIC CORPORATION
8.1.1. Overview
8.1.2. Financial Overview
8.1.3. Product Offerings
8.1.4. Developments
8.1.5. Business Strategy
8.2. EDWARDS LIFESCIENCES CORPORATION
8.2.1. Overview
8.2.2. Financial Overview
8.2.3. Product Offerings
8.2.4. Developments
8.2.5. Business Strategy
8.3. MEDTRONIC
8.3.1. Overview
8.3.2. Financial Overview
8.3.3. Product Offerings
8.3.4. Developments
8.3.5. Business Strategy
8.4. ABBOTT LABORATORIES
8.4.1. Overview
8.4.2. Financial Overview
8.4.3. Product Offerings
8.4.4. Developments
8.4.5. Business Strategy
8.5. ST. JUDE MEDICAL
8.5.1. Overview
8.5.2. Financial Overview
8.5.3. Product Offerings
8.5.4. Developments
8.5.5. Business Strategy
8.6. BIOMERICS
8.6.1. Overview
8.6.2. Financial Overview
8.6.3. Product Offerings
8.6.4. Developments
8.6.5. Business Strategy
8.7. COMED BV
8.7.1. Overview
8.7.2. Financial Overview
8.7.3. Product Offerings
8.7.4. Developments
8.7.5. Business Strategy
8.8. LIVANOVA PLC
8.8.1. Overview
8.8.2. Financial Overview
8.8.3. Product Offerings
8.8.4. Developments
8.8.5. Business Strategy
8.9. JENAVALVE TECHNOLOGY, INC.
8.9.1. Overview
8.9.2. Financial Overview
8.9.3. Product Offerings
8.9.4. Developments
8.9.5. Business Strategy
8.10. CARDIOKINETIX
8.10.1. Overview
8.10.2. Financial Overview
8.10.3. Product Offerings
8.10.4. Developments
8.10.5. Business Strategy

9. Analyst Opinion
10. Annexure
10.1. Report Scope
10.2. Market Definitions
10.3. Research Methodology
10.3.1. Data Collation and In-house Estimation
10.3.2. Market Triangulation
10.3.3. Forecasting
10.4. Report Assumptions
10.5. Declarations
10.6. Stakeholders
10.7. Abbreviations

ページTOPに戻る

List of Tables/Graphs

Tables
TABLE 1. STRUCTURAL HEART DEVICES MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 2. STRUCTURAL HEART DEVICES MARKET VALUE FOR SAVR (SURGICAL AORTIC VALVE REPLACEMENT), BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 3. STRUCTURAL HEART DEVICES MARKET VALUE FOR LOW TEMPERATURE STERILIZERS, BY TAVR (TRANSCATHETER AORTIC VALVE REPLACEMENT), 2021-2030 (USD BILLION)
TABLE 4. STRUCTURAL HEART DEVICES MARKET VALUE FOR MITRAL REPAIR (ANNULOPLASTY), BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. STRUCTURAL HEART DEVICES MARKET VALUE FOR LAAC (LEFT ATRIAL APPENDAGE CLOSURE), BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. NORTH AMERICA Structural Heart Devices Market VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 7. NORTH AMERICA Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 8. NORTH AMERICA Structural Heart Devices Market VALUE, BY RESOLUTION, 2021-2030 (USD BILLION)
TABLE 9. NORTH AMERICA Structural Heart Devices Market VALUE, BY CAMERA TYPE, 2021-2030 (USD BILLION)
TABLE 10. U.S Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 11. U.S Structural Heart Devices Market VALUE, BY RESOLUTION, 2021-2030 (USD BILLION)
TABLE 12. U.S Structural Heart Devices Market VALUE, BY CAMERA TYPE, 2021-2030 (USD BILLION)
TABLE 13. U.S Structural Heart Devices Market VALUE, BY DISEASE INDICATION, 2021-2030 (USD BILLION)
TABLE 14. CANADA Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 15. MEXICO Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 16. EUROPE Structural Heart Devices Market VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 17. GERMANY Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 18. U.K Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 19. FRANCE Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 20. ITALY Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 21. SPAIN Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 22. ROE Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 23. ASIA PACIFIC Structural Heart Devices Market VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 24. CHINA Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 25. INDIA Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 26. JAPAN Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 27. JAPAN Structural Heart Devices Market VALUE, BY RESOLUTION, 2021-2030 (USD BILLION)
TABLE 28. JAPAN Structural Heart Devices Market VALUE, BY CAMERA TYPE, 2021-2030 (USD BILLION)
TABLE 29. REST OF APAC Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 30. LATIN AMERICA Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 31. BRAZIL Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 32. ARGENTINA Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 33. MIDDLE EAST AND AFRICA Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 34. SAUDI ARABIA Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 35. UAE Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 36. REST OF MIDDLE EAST AND AFRICA Structural Heart Devices Market VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 37. BOSTON SCIENTIFIC CORPORATION: FINANCIALS
TABLE 38. BOSTON SCIENTIFIC CORPORATION: PRODUCTS & SERVICES
TABLE 39. BOSTON SCIENTIFIC CORPORATION: RECENT DEVELOPMENTS
TABLE 40. EDWARDS LIFESCIENCES CORPORATION: FINANCIALS
TABLE 41. EDWARDS LIFESCIENCES CORPORATION: PRODUCTS & SERVICES
TABLE 42. EDWARDS LIFESCIENCES CORPORATION: RECENT DEVELOPMENTS
TABLE 43. MEDTRONIC: FINANCIALS
TABLE 44. MEDTRONIC: PRODUCTS & SERVICES
TABLE 45. MEDTRONIC: RECENT DEVELOPMENTS
TABLE 46. ABBOTT LABORATORIES: FINANCIALS
TABLE 47. ABBOTT LABORATORIES: PRODUCTS & SERVICES
TABLE 48. ABBOTT LABORATORIES: RECENT DEVELOPMENTS
TABLE 49. ST. JUDE MEDICAL: FINANCIALS
TABLE 50. ST. JUDE MEDICAL: PRODUCTS & SERVICES
TABLE 51. ST. JUDE MEDICAL: RECENT DEVELOPMENTS
TABLE 52. BIOMERICS: FINANCIALS
TABLE 53. BIOMERICS: PRODUCTS & SERVICES
TABLE 54. BIOMERICS: RECENT DEVELOPMENTS
TABLE 55. COMED BV: FINANCIALS
TABLE 56. COMED BV: PRODUCTS & SERVICES
TABLE 57. COMED BV: DEVELOPMENTS
TABLE 58. LIVANOVA PLC: FINANCIALS
TABLE 59. LIVANOVA PLC: PRODUCTS & SERVICES
TABLE 60. LIVANOVA PLC: RECENT DEVELOPMENTS
TABLE 61. JENAVALVE TECHNOLOGY, INC.: FINANCIALS
TABLE 62. JENAVALVE TECHNOLOGY, INC.: PRODUCTS & SERVICES
TABLE 63. JENAVALVE TECHNOLOGY, INC.: RECENT DEVELOPMENTS
TABLE 64. CARDIOKINETIX: FINANCIALS
TABLE 65. CARDIOKINETIX: PRODUCTS & SERVICES
TABLE 66. CARDIOKINETIX: RECENT DEVELOPMENTS